Published in J Virol on August 13, 2014
Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses. Proc Natl Acad Sci U S A (2016) 0.84
Selection of antigenically advanced variants of seasonal influenza viruses. Nat Microbiol (2016) 0.83
Genome-Wide Analysis of Evolutionary Markers of Human Influenza A(H1N1)pdm09 and A(H3N2) Viruses May Guide Selection of Vaccine Strain Candidates. Genome Biol Evol (2015) 0.82
Antigenic Patterns and Evolution of the Human Influenza A (H1N1) Virus. Sci Rep (2015) 0.81
Selecting vaccine strains for H3N2 human influenza A virus. Meta Gene (2015) 0.77
Predicting the Mutating Distribution at Antigenic Sites of the Influenza Virus. Sci Rep (2016) 0.75
MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 168.89
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature (1981) 15.85
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 11.99
The influenza virus resource at the National Center for Biotechnology Information. J Virol (2007) 11.33
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol (2005) 10.77
A new method of inference of ancestral nucleotide and amino acid sequences. Genetics (1995) 10.23
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Bayesian estimation of ancestral character states on phylogenies. Syst Biol (2004) 7.09
Predicting the evolution of human influenza A. Science (1999) 6.91
A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27
STUDIES OF ANTIGENIC DIFFERENCES AMONG STRAINS OF INFLUENZA A BY MEANS OF RED CELL AGGLUTINATION. J Exp Med (1943) 5.67
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol (1990) 5.37
Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol (1999) 4.97
New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10
Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A (2002) 4.02
Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science (2009) 3.88
Influenza A viruses: new research developments. Nat Rev Microbiol (2011) 3.00
A predictive fitness model for influenza. Nature (2014) 2.73
Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A (2007) 2.67
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A (2012) 2.18
Recent changes among human influenza viruses. Virus Res (2004) 1.98
A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol (2008) 1.96
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol (2010) 1.83
Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog (2012) 1.55
Recommended composition of influenza virus vaccines for use in the 2012–2013 northern hemisphere influenza season. Wkly Epidemiol Rec (2012) 1.48
Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics (2008) 1.47
Identification of novel influenza A virus proteins translated from PA mRNA. J Virol (2012) 1.42
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses (2011) 1.32
Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season. Wkly Epidemiol Rec (2004) 1.27
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci U S A (2011) 1.23
Adaptive evolution: evaluating empirical support for theoretical predictions. Nat Rev Genet (2012) 1.22
Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine (2007) 1.16
Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution. Genome Res (2007) 1.14
Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics (2009) 1.13
Mapping of H3N2 influenza antigenic evolution in China reveals a strategy for vaccine strain recommendation. Nat Commun (2012) 1.12
Recommended composition of influenza virus vaccines for use in the 2005-2006 influenza season. Wkly Epidemiol Rec (2005) 1.09
Allele dynamics plots for the study of evolutionary dynamics in viral populations. Nucleic Acids Res (2010) 1.08
Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. Wkly Epidemiol Rec (2012) 1.07
Use of antigenic cartography in vaccine seed strain selection. Avian Dis (2010) 1.00
Detecting patches of protein sites of influenza A viruses under positive selection. Mol Biol Evol (2012) 0.95
Recommended composition of influenza virus vaccines for use in the 2008-2009 influenza season. Wkly Epidemiol Rec (2008) 0.94
An overview of influenza haemagglutinin and neuraminidase. Biologicals (2009) 0.94
Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season. Wkly Epidemiol Rec (2007) 0.92
Using a mutual information-based site transition network to map the genetic evolution of influenza A/H3N2 virus. Bioinformatics (2009) 0.90
Recommended composition of influenza virus vaccines for use in the 2005 influenza season. Wkly Epidemiol Rec (2004) 0.89
Influenza pandemics: a historical retrospect. J Infect Dev Ctries (2009) 0.88
Recommended composition of influenza virus vaccines for use in the 2003-2004 influenza season. Wkly Epidemiol Rec (2003) 0.87
Recommended composition of influenza virus vaccines for use in the 2008 influenza season. Wkly Epidemiol Rec (2007) 0.83
Recommended composition of influenza virus vaccines for use in the 2006-2007 influenza season. Wkly Epidemiol Rec (2006) 0.83
Inference of genotype-phenotype relationships in the antigenic evolution of human influenza A (H3N2) viruses. PLoS Comput Biol (2012) 0.82
Recommended composition of influenza virus vaccines for use in the 2004 influenza season. Wkly Epidemiol Rec (2003) 0.82
Recommended composition of influenza virus vaccines for use in the 2007 influenza season. Wkly Epidemiol Rec (2006) 0.81
Recommended composition of influenza virus vaccines for use in the 2006 influenza season. Wkly Epidemiol Rec (2005) 0.79